 |
 |
|
|
|
John Scandling, MD (left) and Stéphen Busque, MD, FRCSC (right) |
|
|
How to Participate
Study Goal: To determine whether all anti-rejection drugs can be withdrawn from patients given kidney transplants and an injection of blood cells from a perfectly matched (HLA-identical) donor brother or sister. Currently, kidney transplant patients have to take anti-rejection drugs for the rest of their lives.
To Participate: The patient must have a donor who is a brother or sister. If you are interested in having Stanford staff contact you about this study, please complete the following form below. Then, we will contact you. Email is not secure, so don't include your patient information, just your name and phone number, and the best time to call.
